Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/SG) associated with obesity and vascular risk in children
M Berberoǧlu, O Evliyaoǧlu, P Adıyaman… - Journal of Pediatric …, 2006 - degruyter.com
M Berberoǧlu, O Evliyaoǧlu, P Adıyaman, G Öcal, Β Ulukol, F Şimşek, Ζ Şıklar, Α Törel…
Journal of Pediatric Endocrinology and Metabolism, 2006•degruyter.comAtherothrombotic complications in insulin resistance are partly attributed to impaired
fibrinolysis caused by increased PAI-1 plasma levels, and 4G/5G promoter polymorphism of
the PAI-1 gene may modulate PAI-1 transcription. Objective: To investigate PAI-1-675 4G/5G
allele gene polymorphism and its relationship with obesity in children.
fibrinolysis caused by increased PAI-1 plasma levels, and 4G/5G promoter polymorphism of
the PAI-1 gene may modulate PAI-1 transcription. Objective: To investigate PAI-1-675 4G/5G
allele gene polymorphism and its relationship with obesity in children.
Abstract
Atherothrombotic complications in insulin resistance are partly attributed to impaired fibrinolysis caused by increased PAI-1 plasma levels, and 4G/5G promoter polymorphism of the PAI-1 gene may modulate PAI-1 transcription.
Objective: To investigate PAI-1-675 4G/5G allele gene polymorphism and its relationship with obesity in children.
De Gruyter以上显示的是最相近的搜索结果。 查看全部搜索结果